Singapore-based Zora Health has announced the launch of its integrated fertility care and financing platform, backed by $740K in funding. This investment round saw participation from notable angel investors, including Cheryl Goh (Founding CMO of Grab), Prajit Nanu (CEO of Nium), Alan Jiang (CEO of Beam), and Lisa Enckell (Venture Partner, Antler), as well as Asa Liden (former COO of Pitch.com). Venture…
Fertilis, an Australian medtech company, has developed the prototype of an innovative device, microICSI, aimed at refining the IVF process. A recent study published in the Journal of Assisted Reproduction and Genetics study, titled “A micro-fabricated device (microICSI) improves porcine blastocyst development and procedural efficiency for both porcine intracytoplasmic sperm injection and human microinjection,” now underscores the device’s effectiveness in improving embryo…
IBSA, a pharma company actively involved in reproductive health, has acquired Aura Fertility, an app with the goal of improving the IVF experience. This move is in line with IBSA’s goal to improve patient experiences and outcomes in fertility by focusing on the emotional aspects and challenges associated with IVF. London-based Aura Fertility was established in 2020 by Abi Hannah, Karen Hanson,…
Granata Bio, a biopharma company specializing in fertility medications, has announced the closure of a $14 million Series A funding round. Led by GV (Google Ventures), this funding round includes significant contributions from CooperSurgical, Gedeon Richter, Alumni Ventures, Amboy Street Ventures, Vibe Bio, and others. The investment aims to accelerate the development of Granata Bio’s fertility biopharma pipeline, addressing a critical gap…
Initially the Oura Ring promised better sleep, but its collaboration with Natural Cycles delivered something I hadn’t envisioned: a smart, straightforward way to manage my reproductive health. Starting in August 2022, I began using an Oura Ring alongside Natural Cycles initially for contraception. This partnership has transformed my approach to fertility and contraception, evolving from a background concern into an integrated part…
Marius Pharmaceuticals, a company dedicated to developing therapies for testosterone deficiency, has launched a pilot study focusing on the effects of its oral testosterone therapy, KYZATREX (testosterone undecanoate), on male fertility, specifically spermatogenesis. KYZATREX, approved for testosterone replacement therapy in adult males with testosterone deficiency, will be the subject of this pioneering study. The study aims to explore how this oral testosterone…
ReproTech, a company in the field of cryogenic storage of human reproductive tissue, has announced the launch of its new subsidiary, Cryo-Logix. The initiative aims to provide In vitro fertilization (IVF) clinics with a comprehensive end-to-end cryostorage solution, addressing a long-standing need in the fertility sector. Cryo-Logix emerges as a separate entity under the ReproTech umbrella, with a dedicated focus on enhancing…
In a recent somewhat buzzworthy Bloomberg report, fertility scale-up Kindbody, a trailblazer and well-known unicorn in the femtech world, has come under scrutiny for allegedly nudging its doctors to ramp up egg retrievals — all in the pursuit of beefier profitability margins and the alluring prospect of an IPO. While Kindbody’s growth tactics are currently center stage, it’s crucial to see this…
